Hikma Pharmaceutical reported 685M in Gross Profit on Sales for its second fiscal semester of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Artemis Alpha ATS:LN -9967000 58.81M
AstraZeneca AZN:LN 9.11B 169M
Bayer BAYN:GR 9.46B 2.03B
Fresenius FRE:GR € 2558M 154M
Fresenius Medical Care FMS:US $ 1258.1M 61.07M
Galapagos GLPG:NA 141.11M 42.31M
GlaxoSmithKline GSK:LN 6.14B 283M
GRIFOLS GRF:SM € 580.8M 47.47M
H. Lundbeck A/S LUN:DC 3.53B 474M
Hikma Pharmaceutical HIK:LN 685M 69M
Lonza Group LONN:SW 1.07B 24M
Merck MRK:GR € 3211M 43M
Orion ORNBV:FH 164.5M 10.9M
Recordati REC:IM 303.9M 5.26M